BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31785339)

  • 1. Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma.
    Tinkle CL; Simone B; Chiang J; Li X; Campbell K; Han Y; Li Y; Hover LD; Molitoris JK; Becksfort J; Lucas JT; Patay Z; Baker SJ; Broniscer A; Merchant TE
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):838-847. PubMed ID: 31785339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
    Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
    J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma.
    Hayashi A; Ito E; Omura M; Aida N; Tanaka M; Tanaka Y; Sato H; Miyagawa N; Yokosuka T; Iwasaki F; Hamanoue S; Goto H
    Pediatr Int; 2020 Jan; 62(1):47-51. PubMed ID: 31785177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets.
    Zhu X; Lazow MA; Schafer A; Bartlett A; Senthil Kumar S; Mishra DK; Dexheimer P; DeWire M; Fuller C; Leach JL; Fouladi M; Drissi R
    Acta Neuropathol Commun; 2021 Jan; 9(1):14. PubMed ID: 33431066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy.
    Patay Z; Merchant TE; Nguyen R; Pierson CR; Onar-Thomas A; Broniscer A
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1295-1305. PubMed ID: 29165288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
    Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
    Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG.
    Chiang J; Diaz AK; Makepeace L; Li X; Han Y; Li Y; Klimo P; Boop FA; Baker SJ; Gajjar A; Merchant TE; Ellison DW; Broniscer A; Patay Z; Tinkle CL
    Acta Neuropathol Commun; 2020 Apr; 8(1):57. PubMed ID: 32326973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.
    Freese C; Takiar V; Fouladi M; DeWire M; Breneman J; Pater L
    Pract Radiat Oncol; 2017; 7(2):86-92. PubMed ID: 28274399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Diffuse Intrinsic Pontine Glioma Metastasis Throughout the Brain and Spine.
    Lu VM; Brown DA; Daniels DJ
    World Neurosurg; 2020 Aug; 140():301-302. PubMed ID: 32474088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.
    Zaghloul MS; Eldebawy E; Ahmed S; Mousa AG; Amin A; Refaat A; Zaky I; Elkhateeb N; Sabry M
    Radiother Oncol; 2014 Apr; 111(1):35-40. PubMed ID: 24560760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    Vajapeyam S; Brown D; Billups C; Patay Z; Vezina G; Shiroishi MS; Law M; Baxter P; Onar-Thomas A; Fangusaro JR; Dunkel IJ; Poussaint TY
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):718-724. PubMed ID: 32241771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas.
    Makepeace L; Scoggins M; Mitrea B; Li Y; Edwards A; Tinkle CL; Hwang S; Gajjar A; Patay Z
    AJNR Am J Neuroradiol; 2020 Feb; 41(2):323-330. PubMed ID: 31974084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
    DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
    J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
    Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
    Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study.
    Kim HJ; Lee JH; Kim Y; Lim DH; Park SH; Ahn SD; Kim IA; Im JH; Chung JW; Kim JY; Kim IH; Yoon HI; Suh CO
    Cancer Res Treat; 2023 Jan; 55(1):41-49. PubMed ID: 35255651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2-year-old patient with a diffuse intrinsic pontine glioma and radiation-induced moyamoya syndrome.
    Iizuka A; Shiba N; Shimosato Y; Yoshitomi M; Nakamura T; Miyatake S; Takano Y; Sasaki K; Takeuchi M; Murata H; Yamamoto T; Matsumoto N; Ito S
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28618. PubMed ID: 33460219
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
    Su JM; Murray JC; McNall-Knapp RY; Bowers DC; Shah S; Adesina AM; Paulino AC; Jo E; Mo Q; Baxter PA; Blaney SM
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28283. PubMed ID: 32285998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: A systematic review and meta-analysis.
    Park J; Yea JW; Park JW
    Medicine (Baltimore); 2020 Oct; 99(42):e22721. PubMed ID: 33080729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.
    Crotty EE; Leary SES; Geyer JR; Olson JM; Millard NE; Sato AA; Ermoian RP; Cole BL; Lockwood CM; Paulson VA; Browd SR; Ellenbogen RG; Hauptman JS; Lee A; Ojemann JG; Vitanza NA
    J Neurooncol; 2020 Jul; 148(3):607-617. PubMed ID: 32556862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
    Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
    Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.